New directions in the treatment of opioid withdrawal.
Srivastava AB, Mariani JJ, Levin FR.
Lancet. 2020 Jun 20;395(10241):1938-1948. doi: 10.1016/S0140-6736(20)30852-7.
The fragile state of opioid withdrawal.
Wong W.
Sci Signal. 2023 Feb 14;16(772):eadh0620. doi: 10.1126/scisignal.adh0620. Epub 2023 Feb 14.
Neonatal Abstinence Syndrome.
Jansson LM, Patrick SW.
Pediatr Clin North Am. 2019 Apr;66(2):353-367. doi: 10.1016/j.pcl.2018.12.006.
Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment.
Kosten TR, Baxter LE.
Am J Addict. 2019 Feb;28(2):55-62. doi: 10.1111/ajad.12862. Epub 2019 Jan 31.
Historical Review: Opiate Addiction and Opioid Receptors.
Wang S.
Cell Transplant. 2019 Mar;28(3):233-238. doi: 10.1177/0963689718811060. Epub 2018 Nov 13.
Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations.
Coe MA, Lofwall MR, Walsh SL.
J Addict Med. 2019 Mar/Apr;13(2):93-103. doi: 10.1097/ADM.0000000000000457.
Neonatal opioid withdrawal syndrome.
Sutter MB, Leeman L, Hsi A.
Obstet Gynecol Clin North Am. 2014 Jun;41(2):317-34. doi: 10.1016/j.ogc.2014.02.010.
Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach.
Cohen SM, Weimer MB, Levander XA, Peckham AM, Tetrault JM, Morford KL.
J Addict Med. 2022 Jul-Aug 01;16(4):399-406. doi: 10.1097/ADM.0000000000000945. Epub 2021 Dec 23.
Clinical pharmacology of opioids for pain.
Inturrisi CE.
Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S3-13. doi: 10.1097/00002508-200207001-00002.
Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS).
Mangat AK, Schmölzer GM, Kraft WK.
Semin Fetal Neonatal Med. 2019 Apr;24(2):133-141. doi: 10.1016/j.siny.2019.01.009. Epub 2019 Feb 5.
